RT Journal Article
SR Electronic
T1 Post-COVID-19 syndrome in outpatients: a cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.19.21255742
DO 10.1101/2021.04.19.21255742
A1 Desgranges, Florian
A1 Tadini, Eliana
A1 Munting, Aline
A1 Regina, Jean
A1 Filippidis, Paraskevas
A1 Viala, Benjamin
A1 Karachalias, Eleftherios
A1 Suttels, Véronique
A1 Haefliger, David
A1 Kampouri, Eleftheria
A1 Van Singer, Mathias
A1 Tschopp, Jonathan
A1 Stettler, Laurence Rochat
A1 Schaad, Siméon
A1 Brahier, Thomas
A1 Hugli, Olivier
A1 Chabloz, Yolanda Mueller
A1 Gouveia, Alexandre
A1 Opota, Onya
A1 Carron, Pierre-Nicolas
A1 Guery, Benoît
A1 Papadimitriou-Olivgeris, Matthaios
A1 Boillat-Blanco, Noémie
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/11/06/2021.04.19.21255742.abstract
AB Background After mild COVID-19, some outpatients experience persistent symptoms. However, data are scarce and prospective studies are urgently needed.Objectives To characterize the post-COVID-19 syndrome after mild COVID-19 and identify predictors.Participants Outpatients with symptoms suggestive of COVID-19 with (1) PCR-confirmed COVID-19 (COVID-positive) or (2) SARS-CoV-2 negative PCR (COVID-negative).Design Monocentric cohort study with prospective phone interview between more than three months to ten months after initial visit to the emergency department and outpatient clinics.Main Measures Data of the initial visits were extracted from the electronic medical file. Predefined persistent symptoms were assessed through a structured phone interview. Associations between long-term symptoms and PCR results, as well as predictors of persistent symptoms among COVID-positive, were evaluated by multivariate logistic regression adjusted for age, gender, smoking, comorbidities, and timing of the survey.Key results The study population consisted of 418 COVID-positive and 89 COVID-negative patients, mostly young adults (median age of 41 versus 36 years in COVID-positive and COVID-negative, respectively; p=0.020) and health care workers (67% versus 82%; p=0.006). Median time between the initial visit and the phone survey was 150 days in COVID-positive and 242 days in COVID-negative patients. Persistent symptoms were reported by 223 (53%) COVID-positive and 33 (37%) COVID-negative patients (p=0.006). Overall, 21% COVID-positive and 15% COVID-negative patients (p=0.182) attended care for this purpose. Four surveyed symptoms were independently associated with COVID-19: fatigue (adjusted odds ratio [or] 2.14, 95%CI 1.04-4.41), smell/taste disorder (26.5, 3.46-202), dyspnea (2.81, 1.10-7.16) and memory impairment (5.71, 1.53-21.3). Among COVID-positive, female gender (1.67, 1.09-2.56) and overweight/obesity (1.67, 1.10-2.56) were predictors of persistent symptoms.Conclusions More than half of COVID-positive outpatients report persistent symptoms up to ten months after a mild disease. Only 4 of 14 symptoms were associated with COVID-19 status. The symptoms and predictors of the post-COVID-19 syndrome need further characterization as this condition places a significant burden on society.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by an academic award of the Leenaards Foundation (to NBB), the Infectious Disease Service and the emergency department of Lausanne University Hospital. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was approved by the Ethics Committee of the Canton of Vaud, Switzerland (project-ID CER-VD 2020-01107 and 2019-02283).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, FD, upon reasonable request.